Skip to main content

JPMORGAN CHASE & CO

Position in ABEO — Abeona Therapeutics Inc.

CIK 19617 NEW YORK, NY

Position in ABEO

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$1,193,905
+$1,081,408 QoQ
Shares Held
266,497
+1148.4% QoQ
Ownership
0.468%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority Sole 93% Shared 0% None 7%

Common Shares in ABEO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,579,063,537 across 407 Biotechnology names. ABEO ranks #167 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ABEO

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,193,905 266,497
2025-12-31 $112,497 21,347
2025-09-30 $1,490,326 282,259
2025-06-30 $4,720,828 831,132
2025-03-31 $1,112,692 233,759
2024-12-31 $77 14
2024-09-30 $424,311 67,138
2024-06-30 $163,375 38,532
2024-03-31 $157,063 21,664
2023-12-31 $70 14
2023-09-30 $58 14
2023-06-30 $56 14
2023-03-31 $2,024 718
2022-12-31 $43 14
2022-09-30 $45 15